Rua Bioscience Limited Share Price and Company Fundamentals
Last traded: Yesterday at 11:16 PM
Rua Bioscience Limited engages in the research, development, and sale of pharmaceutical products in New Zealand and internationally. It offers cannabis-derived medicines. The company is also involved in seed production and genetic discovery related activities. In addition, it engages in plant breeding business, as well as involved in plant research activities. Rua Bioscience Limited was formerly known as Hikurangi Cannabis Company Limited and changed its name to Rua Bioscience Limited in October 2019. The company was founded in 2016 and is based in Ruatoria, New Zealand.
Key Metrics
PE ratio
-
PB ratio
1.45
Dividend yield
-
Beta
0.49
Market cap
$10.82M
Enterprise value
$8.17M
Company profile
| Industry / Sector | Drug Manufacturers - Specialty & Generic / Healthcare |
|---|---|
| Website | https://www.ruabio.com |
| Mailing address | 704 Te Araroa Road RD3 Ruatoria 4083 New Zealand |
| Phone / Fax | 64 800 782 246 / |
Dividends
Dividend yield
-
Dividend amount
$-
Payout ratio
0.00%
5Y Avg. yield
-%
Rua Bioscience Limited paid $- dividend and the ex-dividend date was -.The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.RUA dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Mar 2026, following are the company executives and directors listed on Rua Bioscience Limited.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Mr. Paul Naske | Chief Executive Officer | ||
| Mr. Panapa Ehau | Co-Founder & Executive Director | ||
| Mr. Liam Walker | Virtual Chief Financial Officer | ||
| Dr. Jessika Nowak | Technical Director | ||
| Paul Woroniecki | Head of Quality | ||
| Mr. Len Walker | Head of Cultivation at Mangaoporo | ||
| Mr. John Sanders | Chief of Sales & Marketing of Australia | ||
| Porou Tawhiwhirangi | Head Cultivator |
Profitability and management effectiveness
Profit margin
-189.19%
Operating margin
-187.43%
Return on assets
-28.71%
Return on equity
-59.29%
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Rua Bioscience Limited is 10.82M and its enterprise value is 8.17M. The enterprise value to revenue ratio of RUA is 4.47. The enterprise value to EBITDA ratio of RUA is -2.73.
The RUA's stocks Beta value is 0.49 making it 51% less volatile compared to NZX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Rua Bioscience Limited (NZX:RUA) Frequently Asked Questions
1. What is Rua Bioscience Limited's Stock Symbol?
Rua Bioscience Limited trades on NZX under the ticker symbol "RUA".
2. What is Rua Bioscience Limited's stock price today?
One share of RUA stock can currently be purchased for approximately $0.032.
3. How can I contact Rua Bioscience Limited?
Rua Bioscience Limited's mailing address is 704 Te Araroa Road RD3 Ruatoria 4083 New Zealand. The company can be reached via phone at 64 800 782 246.
4. What is Rua Bioscience Limited's official website?
The official website of Rua Bioscience Limited is https://www.ruabio.com.